Olga Brawman-Mintzer, MD | Psychiatrist.com

Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life

Original Research

Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life

August 11, 2025

Augmentation with aripiprazole, but not rTMS, improved quality of life significantly versus venlafaxine XR/duloxetine switch in patients with treatment-resistant depression.

Clotilde Guidetti, Stefania Chaikali, Madhukar H. Trivedi, et al

Original Research

Levetiracetam in Generalized Social Anxiety Disorder: A Double-Blind, Randomized Controlled Trial

December 15, 2009

Olga Brawman-Mintzer, R. Bruce Lydiard, Murray B. Stein, et al

Letter to the Editor

Dr. Brawman-Mintzer and Colleagues Reply to "Sedative Effects of Low-Dose Risperidone in GAD Patients and Risk of Drug Interactions"

August 1, 2006

Olga Brawman-Mintzer, Rebecca G. Knapp, Paul J. Nietert

Original Research

Sertraline Treatment for Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

June 15, 2006

Olga Brawman-Mintzer, Rebecca G. Knapp, Karl Rickels, et al

Original Research

Adjunctive Risperidone in Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study

October 14, 2005

Olga Brawman-Mintzer, Rebecca G. Knapp, Paul J. Nietert

Original Research

The Pharmacologic Treatment of Depression: Is Gender a Critical Factor?

July 16, 2002

Kimberly A. Yonkers, Olga Brawman-Mintzer

Original Research

Once-Weekly Dosing of Fluoxetine in the Maintenance of Remission in Panic Disorder

May 1, 1999

Olga Brawman-Mintzer, R. Bruce Lydiard, Michael R. Ware, et al

Article

Anxious Depression

March 1, 1998

Olga Brawman-Mintzer, R. Bruce Lydiard

Article

Anxious Depression

March 1, 1998

Olga Brawman-Mintzer, R. Bruce Lydiard

Article

Biological Basis of Generalized Anxiety Disorder

March 1, 1997

Olga Brawman-Mintzer, R. Bruce Lydiard